OneGenome vs AlphaGenome: Two Very Different Ways AI Is Decoding DNA
Two of the world's top research labs built AI to decode DNA — and built almost opposite things. That contrast says more about where genetic medicine is heading than either model alone.
DeepMind's AlphaGenome predicts what DNA variants do. BGI's OneGenome reasons from a patient's genome toward a diagnosis. Here's the comparison, and why the answer to "which is better" is "wrong question."
Inside this comparison
- ✓What each model actually does, in plain English
- ✓Scientist's tool vs clinician's tool — the philosophy split
- ✓Where they'd meet in a real patient's journey
- ✓What this East-West divergence signals for medical AI
What's the difference between OneGenome and AlphaGenome?
AlphaGenome is a scientific instrument: it predicts how DNA variants affect gene regulation across long stretches of sequence. OneGenome is a clinical reasoner: it connects a patient's sequencing data to medical literature to suggest diagnoses and treatments. One decodes biology; the other practices something closer to medicine.
One asks 'what does this mutation do?' The other asks 'why is this patient sick?'
Side by side
| AlphaGenome (DeepMind) | OneGenome (BGI-Research) | |
|---|---|---|
| Core question | What does this variant do to gene regulation? | What explains this patient's condition? |
| Input | DNA sequence (up to ~1M letters) | Patient sequencing data + clinical context |
| Output | Predicted molecular effects | Diagnostic hypotheses, medication guidance |
| Primary user | Research scientists | Clinicians, diagnostic teams |
| Access | Research availability via DeepMind | Free and open-source |
| Benchmark claim | State-of-the-art variant effect prediction | Beat DeepSeek-v4 and gene models on clinical tests |
Same patient, two doors
Picture a child with an undiagnosed condition and a genome full of variants of unknown significance. An AlphaGenome-style model helps a researcher ask: does this specific variant disrupt regulation of a gene that could plausibly cause this? A OneGenome-style system attacks from the other side: given everything sequenced and everything published, which diagnostic hypotheses fit this child best, and what has helped similar cases? The first sharpens one piece of evidence; the second assembles the whole case file. A mature genetic-medicine pipeline wants both — prediction feeding reasoning.
The philosophy split worth noticing
It's the medical mirror of the pattern running through all of 2026's AI: Western labs shipping closed instruments, Chinese labs shipping open infrastructure — the same dynamic as Kimi K3 versus the closed flagships. For the full OneGenome story, start with our OneGenome explainer; for the ground-level view of AI in clinics, AI in healthcare 2026.
⚠️ Information, not medical advice
Frequently asked questions
What's the difference between OneGenome and AlphaGenome?+
Which is better, OneGenome or AlphaGenome?+
Are these DNA AI tools available to the public?+
Will AI replace geneticists and genetic counselors?+
Prediction meets reasoning somewhere in the middle of a patient's case file. Whichever lab gets there first, the diagnostic odyssey gets shorter — and that's the only leaderboard that matters here.
Keep Reading
Try Our Free Tools
Want more guides like this?
Join 50K+ readers getting weekly tips on AI, automation & making money online.
Subscribe Free